GL1X · GenesisL1 explorer

MolNFT v1 · #53623 · protein

Inhibition of the exo-beta-D-glucosaminidase csxa by a glucosamine-configured castanospermine and an amino- australine analogue

2X09: “Inhibition of the exo-beta-D-glucosaminidase csxa by a glucosamine-configured castanospermine and an amino…”. X-ray diffraction, 2 ligands (X09, CD), 20 pockets (best druggability 0.73). MolNFT v1 #53623 on GenesisL1: 3D structure…

PDB
2X09
Type
protein
Length
1,700 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Exo-beta-D-glucosaminidase
EC
3.2.1.165
UniProt
Q56F26
Ligands
X09, CD
Pockets
20 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 18% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BExo-beta-D-glucosaminidase (EC 3.2.1.165)protein85018% helix, 35% strandQ56F26

Ligands and binding sites

  • X09 · Amino-australine · ligand · 2 copies · chains A, B
  • CD · Cadmium ion · metal · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 16 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14910.730.8339empty
24470.730.8336empty
34420.650.7855empty
43130.640.8055empty
52590.630.8123empty

Interfaces

1 interface between chains.

  • A–B · 516 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 2X09 · Inhibition of the exo-beta-D-glucosaminidase CsxA by a glucosamine- configured… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q56F26 · AlphaFold monomer V2.0 prediction for exo-beta-D-glucosaminidase (Q56F26) · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.